Abstract
Hyperlipidemia, manifested as turbidity of plasma after an overnight fast, has been recognized in patients with renal disease for over a century. Only since the advent of dialysis treatment, however, has it been possible to determine why large light-scattering triglyceride-rich fat particles accumulate and cause plasma lactescence in many renal failure patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bagdade JD, Porte D Jr, Bierman EL: Hypertriglyceridemia: a metabolic consequence of chronic renal failure. N Engl J Med 269: 181, 1968
Kleinknecht D, Laudat MH, Strauch G, Jungers P, Laudat P: Lipoprotein and carbohydrate disorders in nephrotic syndrome and uremia. Rev Eur Etudes Clin Biol 17: 27, 1972
Brons M, Christensen NC, Horder M: Hyperlipoproteinemia in patients which chronic renal failure. Acta MedScand 192: 119, 1972
Ibels LS, Simons LA, King JO, Williams PF, Neale FC, Stewart JH: Studies on the nature and causes of hyperlipidemia in uremia, maintenance dialysis and renal transplantation. Q J Med 44: 601, 1975
Bagdade JD, Casaretto A, Albers JJ: Effects of chronic uremia, hemodialysis and renal transplantation on plasma lipids and lipoproteins in man. J Lab Clin Med 87: 37, 1976
Daubresse JC, Lerson G, Plomteux G, Rorive G, Luycks AS, Lefebvre PJ: Lipids and lipoproteins in chronic uraemia: a study of the influences of regular haemodialysis. Eur J Clin Invest 6: 159, 1976
Brunzell JD, Albers JJ, Haas LB, Agadoa L, Goldberg AP, Sherrard DJ: Prevalence of serum lipid abnormalities in chronic dialysis. Metabolism 26: 903, 1977
Reaven GM, Lerner MP, Stern MP, Farquhar JW: Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 46: 1756, 1967
Cattran DC, Fenton SA, Wilson DR, Steiner G: Defective triglyceride removal in lipemia associated with peritoneal and haemodialysis. Ann Intern Med 85: 29, 1976
Bagdade JD, Shafrir E, Wilson D: Mechanism(s) of hyperlipidemia in chronic uremia. Trans Am SocArtif Intern Organs 22: 42, 1976
Gregg RC, Diamond A, Mondon CE, Reaven GM: The effects of chronic uremia and dexamethasone on triglyceride kinetics in the rat. Metabolism 26: 875, 1977
Mako M, Block M, Starr J, Nielsen E, Friedman EA, Rubenstein A: Proinsulin in chronic renal and hepatic failure: a reflection of the relative contribution of the liver and the kidney to its metabolism. Clin Res 21:631 A, 1973
Persson B: Lipoprotein lipase activity of human adipose tissue in health and in some diseases with hyperlipi¬demia as a common feature. Acta Med Scand 193: 457, 1973
Bagdade JD, Yee E, Shafrir E, Wilson DE: Hyperlipidemia in renal failure: studies of plasma lipoproteins, hepatic triglyceride production, and tissue lipoprotein lipase in a chronically uremic rat model. J Lab Clin Med 91: 176, 1978
Bagdade JD, Yee E, Albers JJ, Pykalisto OJ: Glucocorticoids and triglyceride transport: effects on trigly-ceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat. Metabolism 25: 533, 1977
Goldberg A, Sherrard D, Brunzell J: Hypertriglyceridemia in hemodialysis patients: dual defect of adipose tissue lipoprotein lipase. Clin Res 24:361 A, 1976
Murase T, Cattran DC, Rubenstein B, Steiner G: Inhibition of lipoprotein lipase by uremic plasma, a pos-sible cause of hypertriglyceridemia. Metabolism 29: 1279, 1975
Bergstrom J, Furst P: Uremic middle molecules. Clin Nephrol 5: 143, 1976
Felts JM, Zacherle B, Staprans I: Mechanisms of hyperlipidemia in chronic renal failure. Proc 9th Ann Contr Conf Artif Kidney Progr NIAMDD DHEW publ no (NIH) 77-467, 1976, p 14
Felts JM, Zacherle B, Staprans I, Itakura H: Mechanisms of hyperlipidemia in chronic failure. Proc 10th Ann Contr Conf Artif Kidney Progr NIAMDD DHEW publ no (NIH) 77-1442, 1977, p. 10
Choi ESK, Chung T, Morrison R, Meyers C, Greenberg M: Hypertriglyceridemia in hemodialysis patients during oral dromostanolone therapy for anemia. Am J Clin Nutr 27: 901, 1974
Glueck CJ, Scheel D, Fishback J, Steiner R: Progestagens, anabolic-androgenic compounds, estrogens: effects on triglycerides and post-heparin lipolytic enzymes. Lipids 7: 110, 1972
Bagdade JD, Livingston R, Yee E: Effects of the synthetic androgen fluoxymesterone on triglyceride secre-tion rates in the rat. Proc Soc Exp Biol Med 149: 452, 1975
Wathen RL, Keshaviah P, Comty C: Acid-base regulation in hemodialysis Proc 10th Ann Contr Conf Artif Kidney Progr NIAMDD DHEW publ no (NIH) 77-1442, 1977, p 17
Davidson WD, Morin RJ, Rorke SJ, Guo LSS: The role of acetate in dialysate for hemodialysis. Proc 10th Ann Contr Conf Artif Kidney Progr NIAMDD DHEW publ no (NIH) 77–1442, 1977, p. 15
Wene JD, Connor WE, Denbesten L: The development of essential fatty acid deficiency in healthy men fed fat-free diets intravenously and orally. J Clin Invest 56: 127, 1975
Basta LL, Williams C, Kioschos JM, Spector AA: Regression of atherosclerotic stenosing lesions of the renal arteries and spontaneous cure of systemic hypertension through control of hyperlipidemia. Am J Med 61: 420, 1976
Haire H, Sherrard D, Scardapane D: Cardiovascular risk factors in dialysis patients. Am Soc Artif Intern Organs (Abstracts) 5: 33, 1976
Sanfelippo ML, Swenson RS, Reaven GM: Efficacy of dietary change on triglyceride and insulin levels in dialyzed and undialyzed subjects with chronic renal failure. Clin Res 25: 139A, 1977
Bagdade JD, Hazzard WR, Carlin J: Effect of unsaturated dietary fat on plasma lipoprotein lipase activity in normal and hyperlipidemic states. Metabolism 19: 1020, 1970
Goldberg A, Sherrard D, Haas L, Brunzell J: Control of Clofibrate toxicity in the treatment of uremic hyper-triglyceridemia. Clin Pharm Ther 21: 314, 1977
Stout RW, Brunzell JD, Porte DP Jr, Bierman EL: The effect of phenformin on lipid transport in hyper-triglyceridemia. Metabolism 23: 815, 1974
Lindner A, Charra B, Sherrard D, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemo-dialysis. N Engl J Med 290: 697, 1974
Cameron JS, Ellis FG, Ogg CS, Bewick M, Boulton-Jones JM, Robinson RD, Harrison J: A comparison of mortality and rehabilitation in regular dialysis and transplantation. Proc Eur Dial Transpl Assoc 7: 25, 1970
Ross R, Glomset JA: The pathogenesis of atherosclerosis. N Engl J Med 295:369 and 420, 1976
Harker LA, Slichter SJ, Scott CR, Ross R: Homocystinemia vascular injury and arterial thrombosis. N Engl J Med 291: 537, 1974
Mordasini R, Frey F, Flury W, Klose G, Greten H: Selective deficiency of hepatic triglyceride lipase in uremic patients. N Engl J Med 297: 1362, 1977
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Martinus Nijhoff Publishers bv, The Hague
About this chapter
Cite this chapter
Bagdade, J.D. (1979). Hyperlipidemia and Atherosclerosis in Chronic Dialysis Patients. In: Drukker, W., Parsons, F.M., Maher, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-9327-3_29
Download citation
DOI: https://doi.org/10.1007/978-94-009-9327-3_29
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-247-2227-3
Online ISBN: 978-94-009-9327-3
eBook Packages: Springer Book Archive